• English

    Google Translate Disclaimer

    The Maryland Department of Information Technology (“DoIT”) offers translations of the content through Google Translate. Because Google Translate is an external website, DoIT does not control the quality or accuracy of translated content. All DoIT content is filtered through Google Translate which may result in unexpected and unpredictable degradation of portions of text, images and the general appearance on translated pages. Google Translate may maintain unique privacy and use policies. These policies are not controlled by DoIT and are not associated with DoIT’s privacy and use policies. After selecting a translation option, users will be notified that they are leaving DoIT’s website. Users should consult the original English content on DoIT’s website if there are any questions about the translated content.

    DoIT uses Google Translate to provide language translations of its content. Google Translate is a free, automated service that relies on data and technology to provide its translations. The Google Translate feature is provided for informational purposes only. Translations cannot be guaranteed as exact or without the inclusion of incorrect or inappropriate language. Google Translate is a third-party service and site users will be leaving DoIT to utilize translated content. As such, DoIT does not guarantee and does not accept responsibility for, the accuracy, reliability, or performance of this service nor the limitations provided by this service, such as the inability to translate specific files like PDFs and graphics (e.g. .jpgs, .gifs, etc.).

    DoIT provides Google Translate as an online tool for its users, but DoIT does not directly endorse the website or imply that it is the only solution available to users. All site visitors may choose to use alternate tools for their translation needs. Any individuals or parties that use DoIT content in translated form, whether by Google Translate or by any other translation services, do so at their own risk. DoIT is not liable for any loss or damages arising out of, or issues related to, the use of or reliance on translated content. DoIT assumes no liability for any site visitor’s activities in connection with use of the Google Translate functionality or content.

    The Google Translate service is a means by which DoIT offers translations of content and is meant solely for the convenience of non-English speaking users of the website. The translated content is provided directly and dynamically by Google; DoIT has no direct control over the translated content as it appears using this tool. Therefore, in all contexts, the English content, as directly provided by DoIT is to be held authoritative.


    Maryland Register

    Issue Date:  April 13, 2018

    Volume 45 • Issue 8 • Pages 427—428


    Title 10


    10.09.15 Podiatry Services

    Authority: Health-General Article, §§2-104(b), 15-103, and 15-105, Annotated Code of Maryland

    Notice of Proposed Action


    The Secretary of Health proposes to amend Regulations .01, .04—.09, and .11 under COMAR 10.09.15 Podiatry Services.

    Statement of Purpose

    The purpose of this action is to update the regulations to further clarify covered services and limitations of podiatric care, as well as an update of specific terms within the regulations.

    Comparison to Federal Standards

    There is no corresponding federal standard to this proposed action.

    Estimate of Economic Impact

    The proposed action has no economic impact.

    Economic Impact on Small Businesses

    The proposed action has minimal or no economic impact on small businesses.

    Impact on Individuals with Disabilities

    The proposed action has no impact on individuals with disabilities.

    Opportunity for Public Comment

    Comments may be sent to Michele Phinney, Director, Office of Regulation and Policy Coordination, Maryland Department of Health, 201 West Preston Street, Room 512, Baltimore, MD 21201, or call 410-767-6499 (TTY 800-735-2258), or email to mdh.regs@maryland.gov, or fax to 410-767-6483. Comments will be accepted through May 14, 2018. A public hearing has not been scheduled.

    .01 Definitions.

    A. In this chapter, the following terms have the meanings indicated.

    B. Terms Defined.

    (1)—(9) (text unchanged)

    (10) “Participant” means an individual who is certified as eligible for, and is receiving, Medical Assistance benefits.

    [(10)] (11)[(14)] (15) (text unchanged)

    [(15)] (16) 'Provider' means an individual, association, partnership, or an incorporated or unincorporated group of podiatrists, duly licensed to provide services for [recipients] participants, and who, through appropriate agreement with the Department, has been identified as a Program provider by the issuance of an individual account number.

    [(16) 'Recipient' means a person who is certified as eligible for, and is receiving, Medical Assistance benefits.]

    (17)—(18) (text unchanged)

    .04 Covered Services.

    The Program covers the following medically necessary services:

    [A. Medically necessary services, when these services are:]

    [(1)] A. [Rendered to a recipient] Podiatric services rendered in the podiatrist's office, the [recipient's] participant’s home, a hospital, a nursing facility, a free standing clinic, or elsewhere[;], when these services are:

    [(2)] (1) Performed by the podiatrist or another licensed podiatrist in [his] the podiatrist’s employ;

    (2) Performed on the:

    (a) Human foot or ankle;

    (b) Anatomical structures that attach to the human foot; or

    (c) Soft tissue below the midcalf;

    (3) Clearly related to the [recipient's] participant’s individual medical needs as diagnostic, curative, palliative, or rehabilitative services; and

    (4) Adequately described on the [recipient's] participant’s medical record.

    B. [Office, home, nursing home, or domiciliary care visits for podiatric care for recipients who are diabetic or who have a vascular disease affecting the lower extremities;] Routine podiatric care rendered in an office, home, nursing home, or licensed assisted living facility for participants who have a metabolic, neurologic, or vascular disease affecting the lower extremities, including but not limited to:

    (1) Arteriosclerosis obliterans (A.S.O., arteriosclerosis of the extremities, occlusive peripheral arteriosclerosis);

    (2) Buerger’s disease (thromboangiitis obliterans);

    (3) Peripheral neuropathies involving the feet, associated with:

    (a) Traumatic injury;

    (b) Leprosy or neurosyphilis; or

    (c) Hereditary disorders, such as hereditary sensory radicular neuropathy, angiokeratoma corporis diffusum (Fabry’s) and amyloid neuropathy; and

    (4) The following conditions, if the patient is under the active care of a doctor of medicine or osteopathy who documents the condition:

    (a) Diabetes mellitus;

    (b) Chronic thrombophlebitis;

    (c) Peripheral neuropathies involving the feet, associated with:

    (i) Malnutrition and vitamin deficiency such as malnutrition (general and pellagra), alcoholism, malabsorption (celiac disease and tropical sprue), and pernicious anemia;

    (ii) Carcinoma;

    (iii) Diabetes mellitus;

    (iv) Drugs and toxins;

    (v) Multiple sclerosis; or

    (vi) Uremia (chronic renal disease).

    C.—F. (text unchanged)

    .05 Limitations.

    A. The Program does not cover the following under this chapter:

    (1)—(7) (text unchanged)

    (8) Visits by or to the podiatrist solely for the purpose of the following:

    (a) Prescription or drug pick-up[,];

    (b) Collection of specimens for laboratory procedures, except by venipuncture, capillary or arterial puncture[,]; and

    (c) (text unchanged)

    (9)—(12) (text unchanged)

    [(13) Corrective shoes;

    (14) Braces;]

    [(15)] (13) (text unchanged)

    [(16)] (14) Routine care, except visits for [recipients] participants who are diabetic or who have a vascular disease affecting the lower extremities;

    [(17)] (15)[(18)] (16) (text unchanged)

    [(19)] (17) Podiatric inpatient hospital services rendered during an admission denied by the utilization control agent or during a period that is in excess of the length of stay authorized by the utilization control agent.

    B. Routine podiatric care is limited to one visit every 60 days for [recipients] participants who have diabetes or peripheral vascular diseases that affect the lower extremities when rendered in the podiatrist's office, the [recipient's] participant’s home, or a nursing facility.

    C. (text unchanged)

    .06 Preauthorization.

    A.—B. (text unchanged)

    C. Preauthorization is valid only for services rendered or initiated within [60] 90 days of the date issued.

    D. (text unchanged)

    .07 Payment Procedures.

    A.—F. (text unchanged)

    G. The provider may not bill the Department or the [recipient] participant for:

    (1)—(5) (text unchanged)

    H. The Program will make no direct payment to [recipients] participants.

    I.—J. (text unchanged)

    .08 Recovery and Reimbursement.

    A. If the [recipient] participant has insurance or other coverage, or if any other person is obligated, either legally or contractually, to pay for or to reimburse the [recipient] participant for services covered by this chapter, the provider shall seek payment from that source first. If an insurance carrier rejects the claim or pays less than the amount allowed by the Medical Assistance Program, the provider may submit a claim to the Program. The provider shall submit a copy of the insurance carrier's notice or remittance advice with his invoice. If payment is made by both the Program and the insurance or other source for the same service, the provider shall refund to the Department, within 60 days of receipt, the amount paid by the Program, or the insurance or other source, whichever is less.

    B. (text unchanged)

    .09 Cause for Suspension or Removal and Imposition of Sanctions.

    A.—D. (text unchanged)

    E. A provider who voluntarily withdraws from the Program, or is removed or suspended from the Program according to this regulation, shall notify [recipients] participants that he or she no longer [honors] accepts Medical Assistance [cards] before [he renders] rendering additional services.

    .11 Interpretive Regulation.

    Except when the language of a specific regulation indicates an intent by the Department to provide reimbursement for covered services to Program [recipients] participants without regard to the availability of federal financial participation, State regulations shall be interpreted in conformity with applicable federal statutes and regulations.

    Secretary of Health